Kari Bechert

Senior Marketing Manager, HCP Programs at Intera Oncology

Kari Bechert has extensive experience in the healthcare industry, specifically in marketing and sales roles. Starting in 2006, Kari worked at Mölnlycke as a Regional Clinical Specialist and later as a Senior Regional Clinical Product Specialist/National and Corporate Field Trainer, where they were responsible for identifying and prioritizing clinical marketing needs and supporting sales initiatives. In 2014, Kari joined MiMedx as a Sales Account Executive, achieving significant sales growth in a short period of time. Kari then moved on to Healogics, Inc. in 2015, serving as a Program Director and leading marketing and operations for a wound center, increasing patient volumes. Kari then transitioned to Integrated Healing Technologies in 2016, initially as a Clinical Sales Training Manager and later as the Director of Clinical Marketing and Sales Training. In these roles, they led the execution of clinical marketing strategies and achieved significant product growth. In 2018, Kari joined Attune Medical as a Marketing Director, driving key business initiatives and implementing marketing campaigns in critical care segments. Most recently, in 2020, Kari became a Channel Marketing Manager Healthcare at Medela, where they reset the organization's marketing fundamentals and led the execution of marketing engagement strategies. In 2023, Kari will join Intera Oncology Inc. as a Marketing Programs Manager.

Kari Bechert obtained a Bachelor of Arts degree in Spanish Language and Literature from Marquette University. Kari later pursued a Masters Degree in Physical Therapy from the same university. In addition to their formal education, Kari has certifications as a Certified Lymphedema Therapist from Norton School and as a Certified Wound Specialist (CWS) from the American Board of Wound Management.

Location

Chicago, United States

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Intera Oncology

1 followers

Intera Oncology specializes in improving the survival of colorectal cancer and cholangiocarcinoma patients. It acquires Oncology and Neuromodulation Drug Delivery products from Johnson & Johnson where they entered an agreement for the sale of the Drug Delivery Oncology/Neuromodulation business to Intera Oncology. This includes accessoriesfor Codman 3000, MedStream, and Model 400/500 pumps.It was founded in 2019 and is headquartered in Wellesley, Massachusetts.